日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effect of multimodal home-based prehabilitation on objectively measured physical activity in patients undergoing elective cardiac or non-cardiac major surgery: secondary outcomes from a randomised controlled trial

多模式居家术前康复对择期心脏或非心脏大手术患者客观测量的身体活动的影响:一项随机对照试验的次要结果

Vetsch, Thomas; Dueblin, Simone Wen-Shi; Eser, Prisca; Beilstein, Christian M; Wuethrich, Patrick Y; Wilhelm, Matthias; Engel, Dominque

Design, synthesis, and structure-activity relationship studies of 6 H-benzo[ b]indeno[1,2- d]thiophen-6-one derivatives as DYRK1A/CLK1/CLK4/haspin inhibitors

H-苯并[b]茚并[1,2-d]噻吩-6-酮衍生物作为 DYRK1A/CLK1/CLK4/haspin 抑制剂的设计、合成及构效关系研究

Abdelfattah Faouzi, Alexandre Arnaud, François Hallé, Jean Roussel, Mandy Aymard, Vincent Denavit, Cong Viet Do, Angélique Mularoni, Mohamed Salah, Ahmed ElHady, Thanh-Nhat Pham, Alexandre Bancet, Marc Le Borgne, Raphaël Terreux, Roland Barret, Matthias Engel, Thierry Lomberget

Molecular insights into the regulatory landscape of PKC-related kinase-2 (PRK2/PKN2) using targeted small compounds

利用靶向小分子化合物深入了解 PKC 相关激酶 2 (PRK2/PKN2) 的调控格局

Lissy Z F Gross, Angelika F Winkel, Facundo Galceran, Jörg O Schulze, Wolfgang Fröhner, Simon Cämmerer, Stefan Zeuzem, Matthias Engel, Alejandro E Leroux, Ricardo M Biondi

N-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer Agents

N-苄基化 5-羟基苯并噻吩-2-甲酰胺作为多靶点 Clk/Dyrk 抑制剂和潜在抗癌剂

Noha Mostafa, Po-Jen Chen, Sarah S Darwish, Yu-Chieh Su, Ming-Hua Shiao, Gary A Piazza, Ashraf H Abadi, Matthias Engel, Mohammad Abdel-Halim

Identification and Biochemical Characterization of Pyrrolidinediones as Novel Inhibitors of the Bacterial Enzyme MurA

吡咯烷二酮作为细菌酶 MurA 新型抑制剂的鉴定和生化特性

Reem K Fathalla, Wolfgang Fröhner, Chantal D Bader, Patrick D Fischer, Charlotte Dahlem, Deep Chatterjee, Sebastian Mathea, Alexandra K Kiemer, Haribabu Arthanari, Rolf Müller, Mohammad Abdel-Halim, Christian Ducho, Matthias Engel

Discovery of novel 6-hydroxybenzothiazole urea derivatives as dual Dyrk1A/α-synuclein aggregation inhibitors with neuroprotective effects

发现新型 6-羟基苯并噻唑尿素衍生物作为具有神经保护作用的双重 Dyrk1A/α-突触核蛋白聚集抑制剂

Yasmeen T AlNajjar, Moustafa Gabr, Ahmed K ElHady, Mohamed Salah, Gerrit Wilms, Ashraf H Abadi, Walter Becker, Mohammad Abdel-Halim, Matthias Engel

From EGFR kinase inhibitors to anti-inflammatory drugs: Optimization and biological evaluation of (4-(phenylamino)quinazolinyl)-phenylthiourea derivatives as novel NF-κB inhibitors

从EGFR激酶抑制剂到抗炎药物:(4-(苯氨基)喹唑啉基)-苯硫脲衍生物作为新型NF-κB抑制剂的优化及生物学评价

Reem A Wagdy, Po-Jen Chen, Mostafa M Hamed, Sarah S Darwish, Shun-Hua Chen, Ashraf H Abadi, Mohammad Abdel-Halim, Tsong-Long Hwang, Matthias Engel

Development of (4-Phenylamino)quinazoline Alkylthiourea Derivatives as Novel NF-κB Inhibitors

(4-苯氨基)喹唑啉烷基硫脲衍生物作为新型 NF-κB 抑制剂的开发

Sarah S Darwish, Po-Jen Chen, Mostafa M Hamed, Reem A Wagdy, Shun-Hua Chen, Ashraf H Abadi, Mohammad Abdel-Halim, Tsong-Long Hwang, Matthias Engel

5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency

5-甲氧基苯并噻吩-2-甲酰胺作为 Clk1/4 抑制剂:选择性和细胞效力的优化

Ahmed K ElHady, Dalia S El-Gamil, Po-Jen Chen, Tsong-Long Hwang, Ashraf H Abadi, Mohammad Abdel-Halim, Matthias Engel

Discovery of Hydroxybenzothiazole Urea Compounds as Multitargeted Agents Suppressing Major Cytotoxic Mechanisms in Neurodegenerative Diseases

发现羟基苯并噻唑脲化合物作为多靶点药物可抑制神经退行性疾病的主要细胞毒机制

Youssef Aboushady, Moustafa Gabr, Ahmed K ElHady, Mohamed Salah, Ashraf H Abadi, Gerrit Wilms, Walter Becker, Mohammad Abdel-Halim, Matthias Engel